Montana HB610 revises preauthorization laws to exempt certain antipsychotic drugs from prior authorization under Medicaid.
Montana HB610 revises preauthorization laws by directing the Department of Public Health and Human Services not to require prior authorization for certain antipsychotic drugs approved by the FDA and recognized by the Diagnostic and Statistical Manual of Mental Disorders. This change applies to claims submitted for payment for services provided after the effective date of the act. The act is set to become effective 30 days after its passage and approval.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.